Sunday, December 18th, 2011 at
In an industry first, Celadon, a major Canadian trucking firm, acknowledged in a recent legal settlement that sleep apnea in one of their drivers most likely led to the death of John Lindsay in a May 2010 trucking collision. Wanda Lindsay, founder of The John Lindsay Foundation, recently announced the $3,250,000 settlement of a lawsuit she and her 3 children filed against Celadon Trucking Company and its driver. The lawsuit arose out of the death of John Lindsay on May 9, 2010.
The Lindsay family was represented by Jim Cole and the Cole, Cole & Easley law firm in Victoria, Texas.
“This is the first case in which a trucking company has acknowledged a death resulting from a driver with sleep apnea,” Cole said. “I believe this will have a national impact on the trucking industry.” Read the rest of this entry
Saturday, December 17th, 2011 at
Graymark Healthcare, Inc. the nation’s second largest provider of diagnostic sleep services and an innovator in comprehensive care for obstructive sleep apnea (OSA), has closed the previously announced agreement to acquire the majority interest in Village Sleep Center in Plano, Texas.
“The acquisition of Village Sleep Center is a great addition to our existing operations in the Dallas Fort Worth area and supports our expansion strategy in existing markets,” said Stanton Nelson, chairman and CEO of Graymark Healthcare. “We look forward to leveraging the professional support staff already established in the region to offer residents of Plano the most comprehensive sleep care available.” Read the rest of this entry
Friday, December 16th, 2011 at
For patients with severe obstructive sleep apnea, three months of continuous positive airway pressure (CPAP) therapy is associated with reduced blood pressure, and partial reversal of metabolic abnormalities, according to a study published in the Dec. 15 issue of the New England Journal of Medicine.
Surendra K. Sharma, M.D., Ph.D., from the All India Institute of Medical Sciences in New Delhi, and colleagues investigated the effects of CPAP treatment on metabolic syndrome in 86 patients with obstructive sleep apnea syndrome. Patients were assigned to real or sham CPAP for three months, followed by a washout period of one month, and then a crossover to the other intervention for three months. Anthropometric variables, blood pressure, fasting blood glucose levels and lipid profile, insulin resistance, glycated hemoglobin levels, carotid intima-media thickness, and visceral fat were measured before and after each intervention. Read the rest of this entry
Thursday, December 15th, 2011 at
Wanda Lindsay, a woman from Texas woman has made her life’s mission to create awareness among the drivers for sleep apnea and various other sleep-related problems traveling America’s highways.
Wanda Lindsay lost her husband a year ago in an accident when his car was struck by a trucker suffering from sleep apnea. John and Wanda Lindsay were traveling from New Braunfels, Texas to Kentucky to visit family. They were stopped in a line of traffic near a construction zone in Texarkana, Texas when a Celedon tractor trailer slammed into the rear of their car. The accident was fatal and John Lindsay lost his life from the injuries in the accident.
“John was a devoted husband and father, he wanted nothing more than to spent his time doing things for his children and for his grandchildren,” said Wanda Lindsay. Read the rest of this entry
Wednesday, December 14th, 2011 at
The Motor Carrier Safety Advisory Committee and the Medical Review Board of the FMCSA held a joint public meeting in Alexandria, VA, to discuss guidance for medical examiners to identify commercial drivers with a high pre-test probability of having Obstructive Sleep Apnea, define conditional certification, and what constitutes immediate disqualification. “These recommendations are a step in the right direction,” commented Richard Thiel, Director of Making Sleep Work For You?, a nationwide sleep disorder program, “both entities recognize how OSA is an issue in the industry, and are taking steps to not only address it, but also give clear guidelines to all stakeholders involved.”
Subcommittees of each group working together will meet in January to draft more detailed recommendations to the FMCSA, and another joint meeting of these entities will take place in February 2012 to finalize the detailed recommendations. A public comment period will also be available before the FMCSA issues these recommendations as final guidance. Read the rest of this entry
Tuesday, December 13th, 2011 at
In a shrewd execution of its business plan and growth strategy, Craig Sizer, Co-founder and Chairman, with Keith Houlihan, Co-founder and President of Sanomedics International Holdings Inc. announced the signing of a letter of intent to acquire a strategically targeted durable medical equipment (DME) provider with a platform in sleep apnea treatment services. The targeted acquisition is accredited by the “Healthcare Quality Association.” The operation with approximately $6 million in revenues and over $1 million in (EBITDA) earnings before interest, taxes, depreciation and amortization is expected to close in early 2012 upon the completion of due diligence and Sanomedics board approval.
“The acquisition of a sleep treatment service based operations is an important step in the growth of Sanomedics, as well as for the distribution and sales expansion of our ThermoMedics line of non-contact clinical thermometers,” said Craig Sizer Chairman and Co-founder. Read the rest of this entry
Monday, December 12th, 2011 at
The Doctors Health Press, a publisher of various natural health newsletters books and reports, including the popular online Doctors Health Press e-Bulletin, is lending its support to a new study that has found combining a Mediterranean diet and regular physical activity could help you improve your night time rest.
As reported in the Doctors Health Press e-Bulletin on Thursday, December 8, 2011, the study looked at how the Mediterranean diet could help obese adults with sleep apnea compared to those with a typical diet.
This health condition causes frequent pauses of breathing to occur during sleep. It can be dangerous over the long term, and is one of the most prevalent sleep-related breathing disorders. Two to four out of every 100 adults experience sleep apnea. But that rises 20% to 40% among obese individuals. Read the rest of this entry
Sunday, December 11th, 2011 at
Researchers at Boston University School of Medicine (BUSM) have identified an intracellular signaling enzyme that regulates the wake-sleep cycle, which could help lead to the development of more effective sleep aid medications. Subimal Datta, PhD, director and principal investigator at the Laboratory of Sleep and Cognitive Neuroscience at BUSM, led the study, which points to a specific enzyme inside neurons in the brain that trigger an important shift in consciousness from sleep to wakefulness and wakefulness to sleep.
The results are published in the November 23 issue of the Journal of Neuroscience. Read the rest of this entry
Saturday, December 10th, 2011 at
The Snoring Center’s Newport Beach office will open on January 9, 2012.The Snoring Center, the nation’s leading provider of minimally invasive, office-based treatment for snoring and sleep apnea, including the Pillar Procedure from Medtronic, announced its second California location, in Newport Beach.
“Healthy, restorative sleep is essential to physical and emotional well being. Snoring and sleep apnea are among the most common sleep disorders, interrupting sleep for literally millions of Americans. The Snoring Center’s innovative approach and progressive treatment options have helped people from around the world get a more peaceful night’s sleep. The opening of another center on the west coast gives more people convenient access to the minimally invasive, office-based snoring and sleep apnea treatment they need”,said Dr.Sharen Jeffries, the Medical Director of the Newport Beach office. Read the rest of this entry
Friday, December 9th, 2011 at
Gone are the days of an unaffordable oral appliance used to treat the deadly disorder Sleep Apnea. With over 18 million Americans affected by Obstructive Sleep Apnea (OSA), it was only a matter of time the market demanded an affordable and effective oral appliance to treat sleep apnea. Respire Medical, a Brooklyn based oral appliance company teamed up with Gergen’s Orthodontic Lab to provide a significantly less expensive solution to the worlds Sleep Apnea sufferers. Dentists can now attend a dental continuing education course offered by Sleep Group Solutions to learn more the Respire Blue Series and offer an affordable option.
“As we continue to grow we would like to welcome all of our new clients and wish them much success in their treatment of OSA with our Respire devices.” says David Walton, co-creator of the Respire Blue Series. “Now that we have been added to the list of Medicare approved devices by the PDAC board, our Respire Blue Series device is available to more people.” With a price point that’s affordable, Respire Medical offers the best value for money across the market, hands down. Read the rest of this entry